SCHEMBL13062073

SCHEMBL13062073

Cc1onc(-c2ccccc2)c1CNC(=O)[C@H](C(C)C)n1cc(-c2ccc(S)cc2)nn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA13 Q8N1Q1 1/20 0.54
CA14 Q9ULX7 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 1/20 0.45
THRB P10828 1/20 0.43
MAPT P10636 2/20 0.42
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
HDAC6 Q9UBN7 4/20 0.42
HDAC3 O15379 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743476 0.88 CA2 (0.71) CA12CA1CA2CA3CA4
SCHEMBL3743483 0.88 CA2 (0.71) CA12CA1CA2CA3CA4
SCHEMBL13062074 0.86 ALDH1A1 (0.46) CA12CA1CA2CA3CA4
SCHEMBL3744470 0.76 CA2 (0.59) CA12CA1CA2CA3CA4
SCHEMBL3744466 0.76 CA2 (0.59) CA12CA1CA2CA3CA4
SCHEMBL17037447 0.75 ALDH1A1 (0.65) ALDH1A1KDM4ETHRBMAPTPLA2G1B
SCHEMBL17040356 0.75 ALDH1A1 (0.67) ALDH1A1KDM4ETHRBMAPTPLA2G1B
SCHEMBL13062070 0.74 CA2 (0.52) CA12CA1CA2CA3CA4
SCHEMBL13062052 0.73 CA2 (0.50) CA12CA1CA2CA3CA4
SCHEMBL13062397 0.72 CA2 (0.47) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317842-A1 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317842-A1 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry CA9, CA4, CA13 CA12 7/4885CA1 5/4885CA2 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.